Antibiotic resistance kills over 50,000 children in India annually

Antibiotic-resistant infections are spreading wings in India, killing over 58,000 children every year, while uncontrolled dumping of untreated urban waste into water bodies is affecting aquatic life and environment.

With some of the highest antibiotic resistant bacteria that commonly cause infections in the community and healthcare facilities, India suffers severely, reminds Centre for Disease Dynamics Economics and Policy (CDDEP), as World Antibiotic Awareness Week 2018 ends on Sunday.

“Every year globally, almost 700,000 lives are lost. More than 58,000 children die every year in India alone, from antibiotic-resistant infections,” said CDDEP.

The antibiotic resistance is the ability of disease-causing bacteria and micro-organisms to resist the antibiotics or medicine due to adaptation.

Earlier in 2017, a team of experts from India and Sweden had also flagged concerns over uncontrolled dumping of partly treated and untreated urban waste into rivers — leading to the spread of antibiotic resistance.

According to CDDEP research, the global use of antibiotics in humans has increased by 65 per cent in 2015 since 2000, while consumption in low- and middle-income countries increased by 114 per cent.

“India saw the highest increase in antibiotic use by 103 per cent. This has resulted in a modern-day crisis with a shortage of effective antibiotics and a weak pipeline for novel antibiotics,” Jyoti Joshi, Head South Asia, CDDEP, said.

The CDDEP research showed that resistance to the broad-spectrum antibiotics is detected in more than 70 per cent of organisms causing pneumonia and sepsis.

“As a leading producer of critical medicines which include antibiotics, India is known as the pharmacy of the world. But the flip side of this is that the toxic effluents from these manufacturing sites wreak an even greater havoc on the Indian rivers and environment,” said Joshi.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’